Answers are grounded in this paper and cite their sources.
Resolving spectral crowding in complex biological matrices remains a formidable challenge in 19F NMR spectroscopy. Herein, we propose a “chemical dimensionality extension” strategy designed to overcome the inherent trade-off between data acquisition speed and spectral resolution. Through the rational design of a multiplex probe containing three chemically nonequivalent fluorine nuclei, we project the identity of a single analyte into a unique set of spatial coordinates within a pseudo-three-dimensional chemical shift space (δF1, δF2, δF3). Remarkably, this high-dimensional fingerprinting is fully realized through a rapid, standard, one-dimensional 19F NMR experiment. This chemical multiplex encoding approach exponentially increases peak capacity and effectively deconvolutes severely overlapping signals, circumventing the need for time-consuming multidimensional pulse sequences. The probe exhibits an exceptionally broad chemical shift window and high quantitative sensitivity, with a limit of detection of 0.8 μM of dopamine. To demonstrate its practical utility, we achieved the accurate quantification of dopamine (R2 = 0.999) and directly confirmed 17 endogenous amino acids from a highly congested crude extract of Ophiopogon japonicus. Ultimately, this study delivers a robust, high-throughput chemical tool for the high-resolution profiling of amine-containing metabolites, signifying a paradigm shift in NMR resolution enhancement from physical instrumentation to rational chemical design.
No takes yet. Share an insight, caveat, or question.
Su et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: